BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Camps J, Joven J. Chemokine ligand 2 and paraoxonase-1 in non-alcoholic fatty liver disease: The search for alternative causative factors. World J Gastroenterol 2015; 21(10): 2875-2882 [PMID: 25780284 DOI: 10.3748/wjg.v21.i10.2875]
URL: https://www.wjgnet.com/1007-9327/full/v21/i10/2875.htm
Number Citing Articles
1
Jordi Camps, Helena Castañé, Elisabet Rodríguez-Tomàs, Gerard Baiges-Gaya, Anna Hernández-Aguilera, Meritxell Arenas, Simona Iftimie, Jorge Joven. On the Role of Paraoxonase-1 and Chemokine Ligand 2 (C-C motif) in Metabolic Alterations Linked to Inflammation and Disease. A 2021 UpdateBiomolecules 2021; 11(7): 971 doi: 10.3390/biom11070971
2
Geoffrey C. Farrell, Fahrettin Haczeyni, Shivakumar Chitturi. Obesity, Fatty Liver and Liver CancerAdvances in Experimental Medicine and Biology 2018; 1061: 19 doi: 10.1007/978-981-10-8684-7_3
3
Eman D. Mohammed, Ashraf B. Abdel-Naim, Jin Kangpeng, Runqiu Jiang, Jifu Wei, Beicheng Sun. The mother relationship between insulin resistance and non-alcoholic steatohepatitis: Glucosinolates hydrolysis products as a promising insulin resistance-modulator and fatty liver-preventerLife Sciences 2021; 264: 118615 doi: 10.1016/j.lfs.2020.118615
4
Zohreh Tehranchinia, Fahimeh Abdollahimajd, Hamidreza Haghighatkhah, Atefeh Talebi, Amin Yarahmadi, Ghazal Zoghi. The frequency of fatty liver in patients with alopecia areata: A case–control studyJournal of Cosmetic Dermatology 2023; 22(9): 2579 doi: 10.1111/jocd.15754
5
Atilla Engin. Obesity and LipotoxicityAdvances in Experimental Medicine and Biology 2024; 1460: 539 doi: 10.1007/978-3-031-63657-8_18
6
Xunzhe Yin, Xiangyu Guo, Zuojia Liu, Jin Wang. Advances in the Diagnosis and Treatment of Non-Alcoholic Fatty Liver DiseaseInternational Journal of Molecular Sciences 2023; 24(3): 2844 doi: 10.3390/ijms24032844
7
Kazuhiko Kotani, Jun Watanabe, Kouichi Miura, Alejandro Gugliucci. Paraoxonase 1 and Non-Alcoholic Fatty Liver Disease: A Meta-AnalysisMolecules 2021; 26(8): 2323 doi: 10.3390/molecules26082323
8
Mohammad Yassin Zamanian, Mehraveh Sadeghi Ivraghi, Lusine G. Khachatryan, Diana E. Vadiyan, Hanie Yavarpour Bali, Maryam Golmohammadi. A review of experimental and clinical studies on the therapeutic effects of pomegranate (Punica granatum) on non‐alcoholic fatty liver disease: Focus on oxidative stress and inflammationFood Science & Nutrition 2023; 11(12): 7485 doi: 10.1002/fsn3.3713
9
Atilla Engin. Obesity and LipotoxicityAdvances in Experimental Medicine and Biology 2017; 960: 443 doi: 10.1007/978-3-319-48382-5_19